Biomarkers of liver fibrosis
Currently the only accepted method (gold standard) for the diagnosis of the fibrotic stages of chronic liver disease (CLD) is liver biopsy, to allow histological assessment. Liver biopsy is an invasive investigation associated with a range adverse events (e.g. pain, haemorrhage) limiting its serial...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Published: |
Wiley
2016
|
| Online Access: | https://eprints.nottingham.ac.uk/34456/ |